Osteoporosis and Hypertrophy
Summary:
Hypertrophy is found among people with Osteoporosis, especially for people who are female, 60+ old.
The study analyzes which people have Hypertrophy with Osteoporosis. It is created by eHealthMe based on reports of 67 people who have Osteoporosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 1,806 drugs and 1,905 conditions by eHealthMe. Check the latest studies of Osteoporosis.
What is Hypertrophy?
Hypertrophy (increase in the volume of an organ or tissue due to the enlargement of its component cells) is found to be associated with 240 drugs and 292 conditions by eHealthMe. Check the latest studies of Hypertrophy.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
67 people who have Osteoporosis and Hypertrophy are studied.

Gender of people who have Osteoporosis and experienced Hypertrophy *:
- female: 70.49 %
- male: 29.51 %
Age of people who have Osteoporosis and experienced Hypertrophy *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.5 %
- 20-29: 0.0 %
- 30-39: 2.5 %
- 40-49: 17.5 %
- 50-59: 12.5 %
- 60+: 65.0 %
Common co-existing conditions for these people *:
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 11.94%
- Back Pain: 8 people, 11.94%
- Osteopenia (a condition where bone mineral density is lower than normal): 7 people, 10.45%
- Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 10.45%
- Constipation: 7 people, 10.45%
- Metastases To Bone (cancer spreads to bone): 4 people, 5.97%
- Benign Neoplasm Of Thyroid Gland (benign (non-cancerous) tumours of the thyroid gland): 3 people, 4.48%
- Neck Injury: 3 people, 4.48%
- Arthropathy: 3 people, 4.48%
- Diabetes: 3 people, 4.48%
Common drugs taken by these people *:
- Fosamax: 42 people, 62.69%
- Alendronate Sodium: 17 people, 25.37%
- Boniva: 11 people, 16.42%
- Zometa: 9 people, 13.43%
- Reclast: 9 people, 13.43%
- Prednisolone: 8 people, 11.94%
- Actonel: 8 people, 11.94%
- Fosamax Plus D: 8 people, 11.94%
- Lioresal: 7 people, 10.45%
- Depakene: 7 people, 10.45%
Common symptoms for these people *:
- Fall: 36 people, 53.73%
- High Blood Pressure: 35 people, 52.24%
- Femur Fracture: 33 people, 49.25%
- Spinal Osteoarthritis (joint cartilage loss in spine): 32 people, 47.76%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 31 people, 46.27%
- Intervertebral Disc Protrusion (spinal disc protrusion): 29 people, 43.28%
- Intervertebral Disc Degeneration (spinal disc degeneration): 25 people, 37.31%
- Stress And Anxiety: 25 people, 37.31%
- Depression: 24 people, 35.82%
- Osteopenia (a condition where bone mineral density is lower than normal): 22 people, 32.84%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Hypertrophy?
- Check whether Hypertrophy is associated with a drug or a conditionRelated publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Related studies:
Treatments, associated drugs and conditions:
- Osteoporosis (290,734 reports)
- Hypertrophy (835 reports)
All the drugs that are associated with Hypertrophy:
- Hypertrophy (240 drugs)
All the conditions that are associated with Hypertrophy:
- Hypertrophy (292 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Hypertrophy and Osteoporosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cataplexy and Occipital Neuralgia - a second ago
- Could Gabitril cause Nausea Aggravated? - 9 seconds ago
- Could Paroxetine cause Escherichia Infection? - 18 seconds ago
- Could Cymbalta cause Incision Site Infection? - 23 seconds ago
- Could Fuzeon cause Suicidal Ideation? - 27 seconds ago
- Could Folate cause Cyst? - 48 seconds ago
- Could Flurbiprofen cause Acute Kidney Failure? - 53 seconds ago
- Drug interactions of Esomeprazole Magnesium and Flurbiprofen - a minute ago
- Could Mometasone Furoate cause Musculoskeletal Pain? - a minute ago
- Tramadol and Parkinson'S Disease Aggravated for Women aged 60+ - a minute ago